• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞脂肪毒性中调节转录机制的表征。

Characterization of regulatory transcriptional mechanisms in hepatocyte lipotoxicity.

机构信息

Biozentrum, University of Basel, 4056, Basel, Switzerland.

Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.

出版信息

Sci Rep. 2022 Jul 7;12(1):11477. doi: 10.1038/s41598-022-15731-4.

DOI:10.1038/s41598-022-15731-4
PMID:35798791
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9262951/
Abstract

Non-alcoholic fatty liver disease is a continuum of disorders among which non-alcoholic steatohepatitis (NASH) is particularly associated with a negative prognosis. Hepatocyte lipotoxicity is one of the main pathogenic factors of liver fibrosis and NASH. However, the molecular mechanisms regulating this process are poorly understood. The main aim of this study was to dissect transcriptional mechanisms regulated by lipotoxicity in hepatocytes. We achieved this aim by combining transcriptomic, proteomic and chromatin accessibility analyses from human liver and mouse hepatocytes. This integrative approach revealed several transcription factor networks deregulated by NASH and lipotoxicity. To validate these predictions, genetic deletion of the transcription factors MAFK and TCF4 was performed, resulting in hepatocytes that were better protected against saturated fatty acid oversupply. MAFK- and TCF4-regulated gene expression profiles suggest a mitigating effect against cell stress, while promoting cell survival and growth. Moreover, in the context of lipotoxicity, some MAFK and TCF4 target genes were to the corresponding differentially regulated transcripts in human liver fibrosis. Collectively, our findings comprehensively profile the transcriptional response to lipotoxicity in hepatocytes, revealing new molecular insights and providing a valuable resource for future endeavours to tackle the molecular mechanisms of NASH.

摘要

非酒精性脂肪性肝病是一种疾病谱,其中非酒精性脂肪性肝炎(NASH)尤其与不良预后相关。肝细胞脂肪毒性是肝纤维化和 NASH 的主要致病因素之一。然而,调节这一过程的分子机制尚不清楚。本研究的主要目的是剖析肝细胞脂肪毒性调节的转录机制。我们通过对人肝和鼠肝细胞的转录组、蛋白质组和染色质可及性分析来实现这一目标。这种综合方法揭示了 NASH 和脂肪毒性失调的几个转录因子网络。为了验证这些预测,我们对转录因子 MAFK 和 TCF4 进行了基因缺失,结果发现这些细胞对饱和脂肪酸供应过剩有更好的保护作用。MAFK 和 TCF4 调节的基因表达谱表明它们具有减轻细胞应激的作用,同时促进细胞存活和生长。此外,在脂肪毒性的情况下,一些 MAFK 和 TCF4 的靶基因与人类肝纤维化中相应的差异调节转录物相对应。总之,我们的研究结果全面描绘了肝细胞对脂肪毒性的转录反应,揭示了新的分子见解,并为未来解决 NASH 的分子机制提供了有价值的资源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f471/9262951/25da83779568/41598_2022_15731_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f471/9262951/e6b83e3604dd/41598_2022_15731_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f471/9262951/096f4e3eae2f/41598_2022_15731_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f471/9262951/4399dd4461c2/41598_2022_15731_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f471/9262951/b90a2c895d4d/41598_2022_15731_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f471/9262951/f08f26bfa0ea/41598_2022_15731_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f471/9262951/222b24a01541/41598_2022_15731_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f471/9262951/25da83779568/41598_2022_15731_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f471/9262951/e6b83e3604dd/41598_2022_15731_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f471/9262951/096f4e3eae2f/41598_2022_15731_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f471/9262951/4399dd4461c2/41598_2022_15731_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f471/9262951/b90a2c895d4d/41598_2022_15731_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f471/9262951/f08f26bfa0ea/41598_2022_15731_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f471/9262951/222b24a01541/41598_2022_15731_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f471/9262951/25da83779568/41598_2022_15731_Fig7_HTML.jpg

相似文献

1
Characterization of regulatory transcriptional mechanisms in hepatocyte lipotoxicity.肝细胞脂肪毒性中调节转录机制的表征。
Sci Rep. 2022 Jul 7;12(1):11477. doi: 10.1038/s41598-022-15731-4.
2
IRE1A Stimulates Hepatocyte-Derived Extracellular Vesicles That Promote Inflammation in Mice With Steatohepatitis.IRE1A 刺激肝细胞来源的细胞外囊泡,促进脂肪性肝炎小鼠的炎症反应。
Gastroenterology. 2020 Oct;159(4):1487-1503.e17. doi: 10.1053/j.gastro.2020.06.031. Epub 2020 Jun 20.
3
Nonalcoholic Steatohepatitis.非酒精性脂肪性肝炎。
Annu Rev Med. 2017 Jan 14;68:85-98. doi: 10.1146/annurev-med-051215-031109. Epub 2016 Oct 5.
4
Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation.非酒精性脂肪性肝炎发病机制:亚致死性肝细胞损伤作为肝脏炎症的驱动因素。
Gut. 2018 May;67(5):963-972. doi: 10.1136/gutjnl-2017-315691. Epub 2018 Jan 24.
5
The transcription factor c-Jun/AP-1 promotes liver fibrosis during non-alcoholic steatohepatitis by regulating Osteopontin expression.转录因子 c-Jun/AP-1 通过调节骨桥蛋白表达促进非酒精性脂肪性肝炎肝纤维化。
Cell Death Differ. 2019 Sep;26(9):1688-1699. doi: 10.1038/s41418-018-0239-8. Epub 2019 Feb 18.
6
Oleic acid protects saturated fatty acid mediated lipotoxicity in hepatocytes and rat of non-alcoholic steatohepatitis.油酸可保护肝细胞及非酒精性脂肪性肝炎大鼠中饱和脂肪酸介导的脂毒性。
Life Sci. 2018 Jun 15;203:291-304. doi: 10.1016/j.lfs.2018.04.022. Epub 2018 Apr 27.
7
Reduced lipoapoptosis, hedgehog pathway activation and fibrosis in caspase-2 deficient mice with non-alcoholic steatohepatitis.非酒精性脂肪性肝炎的caspase-2缺陷小鼠中脂凋亡减少、刺猬信号通路激活及纤维化减轻
Gut. 2015 Jul;64(7):1148-57. doi: 10.1136/gutjnl-2014-307362. Epub 2014 Jul 22.
8
Myristic acid potentiates palmitic acid-induced lipotoxicity and steatohepatitis associated with lipodystrophy by sustaning de novo ceramide synthesis.肉豆蔻酸通过持续从头合成神经酰胺,增强棕榈酸诱导的与脂肪营养不良相关的脂毒性和脂肪性肝炎。
Oncotarget. 2015 Dec 8;6(39):41479-96. doi: 10.18632/oncotarget.6286.
9
Hepatocyte nuclear receptor SHP suppresses inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis.肝细胞核受体 SHP 抑制非酒精性脂肪性肝炎小鼠模型中的炎症和纤维化。
J Biol Chem. 2018 Jun 1;293(22):8656-8671. doi: 10.1074/jbc.RA117.001653. Epub 2018 Apr 17.
10
Nobiletin mitigates hepatocytes death, liver inflammation, and fibrosis in a murine model of NASH through modulating hepatic oxidative stress and mitochondrial dysfunction.川陈皮素通过调节肝氧化应激和线粒体功能障碍减轻 NASH 小鼠模型肝细胞死亡、肝脏炎症和纤维化。
J Nutr Biochem. 2022 Feb;100:108888. doi: 10.1016/j.jnutbio.2021.108888. Epub 2021 Oct 22.

引用本文的文献

1
Chromatin accessibility: biological functions, molecular mechanisms and therapeutic application.染色质可及性:生物学功能、分子机制及治疗应用
Signal Transduct Target Ther. 2024 Dec 4;9(1):340. doi: 10.1038/s41392-024-02030-9.
2
Spatial genomics: mapping human steatotic liver disease.空间基因组学:绘制人类脂肪变性肝病图谱。
Nat Rev Gastroenterol Hepatol. 2024 Sep;21(9):646-660. doi: 10.1038/s41575-024-00915-2. Epub 2024 Apr 23.
3
Zinc finger transcription factor Egf1 promotes non-alcoholic fatty liver disease.锌指转录因子Egf1促进非酒精性脂肪性肝病。

本文引用的文献

1
Liver-fibrosis-activated transcriptional networks govern hepatocyte reprogramming and intra-hepatic communication.肝纤维化激活的转录网络调控肝实质细胞的重编程和肝内通讯。
Cell Metab. 2021 Aug 3;33(8):1685-1700.e9. doi: 10.1016/j.cmet.2021.06.005. Epub 2021 Jul 7.
2
Review of galectin-3 inhibitors in the treatment of nonalcoholic steatohepatitis.Galectin-3 抑制剂治疗非酒精性脂肪性肝炎的研究进展。
Expert Rev Clin Pharmacol. 2021 Apr;14(4):457-464. doi: 10.1080/17512433.2021.1894127. Epub 2021 Mar 2.
3
Therapeutic pipeline in nonalcoholic steatohepatitis.
JHEP Rep. 2023 Mar 9;5(6):100724. doi: 10.1016/j.jhepr.2023.100724. eCollection 2023 Jun.
4
Positive allosteric GABA receptor modulation counteracts lipotoxicity-induced gene expression changes in hepatocytes .正向变构性γ-氨基丁酸受体调节可抵消脂肪毒性诱导的肝细胞基因表达变化。
Front Physiol. 2023 Feb 13;14:1106075. doi: 10.3389/fphys.2023.1106075. eCollection 2023.
非酒精性脂肪性肝炎的治疗药物研发管线。
Nat Rev Gastroenterol Hepatol. 2021 Jun;18(6):373-392. doi: 10.1038/s41575-020-00408-y. Epub 2021 Feb 10.
4
Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis.非酒精性脂肪性肝病谱中的转录组特征分析揭示了肝脂肪变性和纤维化的基因特征。
Sci Transl Med. 2020 Dec 2;12(572). doi: 10.1126/scitranslmed.aba4448.
5
Nuclear receptors and transcriptional regulation in non-alcoholic fatty liver disease.核受体与非酒精性脂肪性肝病的转录调控。
Mol Metab. 2021 Aug;50:101119. doi: 10.1016/j.molmet.2020.101119. Epub 2020 Nov 18.
6
Mechanisms, regulation and functions of the unfolded protein response.未折叠蛋白反应的机制、调控和功能。
Nat Rev Mol Cell Biol. 2020 Aug;21(8):421-438. doi: 10.1038/s41580-020-0250-z. Epub 2020 May 26.
7
Cardiolipin Synthase 1 Ameliorates NASH Through Activating Transcription Factor 3 Transcriptional Inactivation.心磷脂合成酶 1 通过激活转录因子 3 的转录失活来改善 NASH。
Hepatology. 2020 Dec;72(6):1949-1967. doi: 10.1002/hep.31202. Epub 2020 Nov 6.
8
Cadherin-11 contributes to liver fibrosis induced by carbon tetrachloride.钙黏蛋白 11 促进四氯化碳诱导的肝纤维化。
PLoS One. 2019 Jul 3;14(7):e0218971. doi: 10.1371/journal.pone.0218971. eCollection 2019.
9
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets.Metascape 为系统水平数据集的分析提供了面向生物学家的资源。
Nat Commun. 2019 Apr 3;10(1):1523. doi: 10.1038/s41467-019-09234-6.
10
Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.与健康正常体重个体相比,不同程度非酒精性脂肪性肝病患者的肝转录组特征。
Am J Physiol Gastrointest Liver Physiol. 2019 Apr 1;316(4):G462-G472. doi: 10.1152/ajpgi.00358.2018. Epub 2019 Jan 17.